Cytosorbents Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Cytosorbents Contact Number

Contact Us Cytosorbents

4 hours ago Cytosorbents.com Show details

732.329.8885

CytoSorbents Corporation 7 Deer Park Drive, Suite K Monmouth Junction, NJ 08852 United States Phone: 732.329.8885 Fax: 732.329.8650 Email: …

Category: Contact SupportShow more

Contact Us Cytosorbents

8 hours ago Dev.cytosorbents.com Show details

732.329.8885

For Clinical Inquiries, please contact: Dr. Phillip Chan, MD, PhD President and CEO Phone: 732.329.8885 ext. *426 Email: [email protected]cytosorbents.com For Investor Inquiries

Category: Contact SupportShow more

Cytosorbents Corporation Company Profile Monmouth

8 hours ago Dnb.com Show details

(732) 329-8885

Phone. (732) 329-8885. Company Description. Cytosorbents Corporation is located in Monmouth Junction, NJ, United States and is part of the Medical Equipment & Supplies Manufacturing Industry. Cytosorbents Corporation has 84 total employees across all of its locations and generates $41.00 million in sales (USD).

Employees: 84
Phone: (732) 329-8885
Location: 7 Deerpark Dr Ste K, Monmouth Junction, 08852-1977, NJ

Category: Contact NumberShow more

Cytosorbents Crunchbase Company Profile & Funding

2 hours ago Crunchbase.com Show details

Contact Email [email protected]cytosorbents.com. Phone Number 7323298650. CytoSorbents Corporation is a publicly-traded, critical care focused therapeutic device company using blood purification to treat life-threatening illnesses. Its purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances

Founder: Frank Clark
Location: Monmouth Junction, New Jersey
Founded: Jul 01, 2007

Category: Contact NumberShow more

Welcome to CytoSorbents Corporation

5 hours ago Cytosorbents.com Show details

CytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based, critical care company specializing in blood purification to treat life-threatening conditions in the intensive care unit and cardiac surgery.

Category: Contact NumberShow more

Privacy Information Cytosorbents

5 hours ago Cytosorbents.com Show details

30 6549 9145

Who is responsible for data processing and who can you contact? Responsible for. CytoSorbents Europe GmbH. Müggelseedamm 131. 12587 Berlin, Germany. [email protected]cytosorbents.com. +49 (0) 30 6549 9145. The company data protection officer is. Richard Söldner.

Category: Contact NumberShow more

CytoSorbents Switzerland GmbH Company Profile …

3 hours ago Dnb.com Show details

CytoSorbents Switzerland GmbH is located in Reinach BL, BASEL-LAND, Switzerland and is part of the Medical Equipment & Supply Wholesalers Industry. CytoSorbents Switzerland GmbH has 3 employees at this location and generates $741,528 in sales (USD). There are 5 companies in the CytoSorbents Switzerland GmbH corporate family.

Category: Contact NumberShow more

Privacy Policy CytoSorbents Europe GmbH

8 hours ago Cytosorb-therapy.com Show details

30 6549 9145

CytoSorbents Europe GmbH Müggelseedamm 131 12587 Berlin, Germany [email protected] +49 (0) 30 6549 9145. The company data protection officer is company, commercial register number, VAT number, company number, address, contact details (e-mail address, telephone number, fax), bank details. Visitors to our company include their name and

Category: Contact NumberShow more

CytoSorb Home CytoSorbents Europe GmbH

5 hours ago Cytosorb-therapy.com Show details

COVID-19 & CytoSorb Therapy* CytoSorb Therapy may be a promising and important therapeutic option to help manage the serious complications caused by cytokine storm and hyperinflammation in critically ill COVID-19 infected patients. Initial reports suggest that COVID-19 is associated with severe disease that requires intensive care in approximately 5% of proven infections. The …

Category: Home PhoneShow more

About us CytoSorbents Europe GmbH

1 hours ago Cytosorb-therapy.com Show details

Since the start in 2012, the entire company CytoSorbents has taken a very successful development. The products are now represented in 65 countries on five continents. More than 1000 clinical departments work with CytoSorb. In addition, the number of scientific publications and studies continues to grow year after year.

Category: Contact NumberShow more

HemoDefend Cytosorbents

9 hours ago Dev.cytosorbents.com Show details

HemoDefend™ is an extension of CytoSorbents’ powerful bead-based blood purification technology and is designed to improve the safety and quality of the blood supply. Each year, there are an estimated 100 million transfusions of blood products worldwide, each with a 1-5% risk of a transfusion reaction. These reactions can be as mild as fever or […]

Category: Contact NumberShow more

About Us Cytosorbents

4 hours ago Dev.cytosorbents.com Show details

About Us. CytoSorbents Corporation (NASDAQ: CTSO) is a New Jersey-based, critical care immunotherapy company specializing in blood purification to control deadly inflammation in critically-ill and cardiac surgery patients. The company’s flagship product, CytoSorb®, is approved in the European Union with distribution in 58 countries around

Category: Contact NumberShow more

CytoSorbents Corporation LinkedIn

5 hours ago Linkedin.com Show details

CytoSorbents (NASDAQ: CTSO) CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European

Category: Contact NumberShow more

CytoSorbents Receives Full FDA Investigational Device

4 hours ago Cytosorbents.com Show details

212-805-3052

[email protected]cytosorbents.com. U.S. Public Relations Contact: Eric Kim Rubenstein Public Relations 212-805-3052 [email protected] . 1 Agency for Healthcare Research and Quality. Number of people with purchase in thousands by prescribed drug, United States, 1996-2018. Medical Expenditure Panel Survey. Generated interactively May 27, 2021

Category: Contact NumberShow more

SEC Filings Cytosorbents

1 hours ago Cytosorbents.com Show details

contact CytoSorbents is a leader in critical care immunotherapy. The company is committed to serving the best interests of our patients and their families, our customers, our employees, and our shareholders.

Category: Contact NumberShow more

CytoSorb Cytosorbents

8 hours ago Dev.cytosorbents.com Show details

CytoSorb® is the first specifically approved extracorporeal cytokine adsorber in the European Union, designed to reduce the “fuel to the fire” of deadly inflammation often seen in critically-ill patients in the intensive care unit (ICU) and those undergoing complex open heart surgery. Specifically, CytoSorb is approved to reduce toxic levels of cytokines, often called a […]

Category: Contact NumberShow more

CytoSorbents Receives Full FDA Investigational Device

5 hours ago Wbtv.com Show details

212-805-3052

U.S. Public Relations Contact: Eric Kim Rubenstein Public Relations 212-805-3052 [email protected] 1 Agency for Healthcare Research and Quality. Number of people with purchase in thousands by prescribed drug, United States, 1996-2018. Medical Expenditure Panel Survey. Generated interactively May 27, 2021. CytoSorbents estimates.

Category: Contact NumberShow more

CytoSorbents Provides Preliminary Third Quarter Business

3 hours ago Finance.yahoo.com Show details

Preliminary third quarter 2021 total revenue was $9.7 million, including product sales of $8.9 million. Preliminary core non-COVID-19 product sales increased 4% Y-Y to approximately $7.8 million

Category: Contact NumberShow more

Cytosorbents Number of Employees 20072021 CTSO

9 hours ago Macrotrends.net Show details

Dividend Yield History. Number of Employees. Cytosorbents number of employees from 2007 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Compare CTSO With Other Stocks. Cytosorbents Annual Number of Employees. 2020. 195.

Category: Contact NumberShow more

Cytosorbents Corporation (CTSO): The long term indicators

6 hours ago Baxterreport.com Show details

The total number of common shares currently owned by the public is 43.32 million. CTSO does have institutional investors; and they hold 43.60% of the stock. Cytosorbents Corporation – Insider Activity and Holdings. Moreover, the latest SEC filings also revealed that stock came across 1 new insider purchases involving 4,000 shares.

Category: Contact NumberShow more

Here’s How Your Trade Cytosorbents Corporation (CTSO

8 hours ago Newsheater.com Show details

Cytosorbents Corporation (NASDAQ:CTSO) went down by -17.54% from its latest closing price compared to the recent 1-year high of $11.68. The company’s stock price has collected -1.48% of loss in the last five trading sessions. Press Release reported on 09/14/21 that CytoSorbents to Host International Webinar on the Worldwide Experience Using CytoSorb(R) …

Category: Contact NumberShow more

CytoSorbents Receives Full FDA Investigational Device

5 hours ago Whsv.com Show details

212-805-3052

U.S. Public Relations Contact: Eric Kim Rubenstein Public Relations 212-805-3052 [email protected] 1 Agency for Healthcare Research and Quality. Number of people with purchase in thousands by

Category: Contact NumberShow more

Coverage Initiated by B. Riley for Cytosorbents (NASDAQ:CTSO)

6 hours ago Stockmarketdaily.co Show details

Stock analysts at B. Riley initiated coverage on shares of Cytosorbents (NASDAQ:CTSO) in a report issued on wednesday. The brokerage set a Buy rating on the Medical stock. A price-to-earnings ratio of #N/A and a beta of 0.42. Cytosorbents has a twelve month low $6.04 of and a twelve month high of $11.68.

Category: Contact NumberShow more

Cytosorbents Europe GmbH EORISearch.com Value Added

4 hours ago Eori-search.com Show details

XI 330778934 Cytosorbents UK Limited 19 The Hundred, Romsey, Hampshire, SO51 8GD GB 330 511838 Cytosorbents UK Limited 19 The Hundred, Romsey, Hampshire , SO51 8GD DK 378 92290 Sevone UK Ltd Azets Insight A/S, Lyskær 3, DK-2730 Herlev (Herlev)

Category: Contact NumberShow more

CytoSorbents Announces Lease of New Global Headquarters in

4 hours ago Finance.yahoo.com Show details

CytoSorbents to Consolidate Operations and to Quintuple Manufacturing Capacity at new Headquarters in Princeton, NJ. Mr. Vincent Capponi, MS, President and Chief Operating Officer of CytoSorbents

Category: Contact NumberShow more

CytoSorbents Receives Full FDA Investigational Device

7 hours ago Wfmz.com Show details

MONMOUTH JUNCTION, N.J., Oct. 12, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using

Category: Contact NumberShow more

Cytosorbents Corp (Form: S1/A, Received: 12/30/2014 16:54:54)

4 hours ago Content.edgar-online.com Show details

(732) 329-8885

Classification Code Number) (I.R.S. Employer Identification Number) 7 Deer Park Drive, Suite K Monmouth Junction, New Jersey 08852 (732) 329-8885 (Address, including zip code, and telephone number, CYTOSORBENTS CORPORATION 1,250,000 SHARES OF COMMON STOCK We are offering 1,250,000 shares of our common stock. The offering price per share …

Category: Contact NumberShow more

First Patient Enrolled in U.S. START Pivotal Trial

5 hours ago Finance.yahoo.com Show details

First Patient Enrolled in U.S. STAR-T Trial Evaluating DrugSorb-ATR™ to Remove Ticagrelor During Cardiothoracic Surgery. Dr. Bradley S. Taylor stated, "Ticagrelor is an antiplatelet agent

Category: Contact NumberShow more

CYTOSORBENTS CORP : Other Events (form 8K) MarketScreener

1 hours ago Marketscreener.com Show details

Item 8.01 Other Events On October 7, 2021, CytoSorbents Corporation (the "Company") issued a press release announcing the public availability of preliminary data abstracts from two separate endocarditis studies, including the REMOVE study, to be presented at the upcoming European Association for Cardio-Thoracic Surgery (EACTS) annual meeting taking …

Category: Contact NumberShow more

CytoSorbents : Announces Filing of an Investigational

7 hours ago Marketscreener.com Show details

(732) 482-9984

Investor Relations Contact: Terri Anne Powers Vice President, Investor Relations and Corporate Communications (732) 482-9984 [email protected]cytosorbents.com. U.S. Public Relations Contact: Eric Kim Rubenstein Public Relations 212-805-3052 [email protected]

Category: Contact NumberShow more

Medical sector's Cytosorbents (NASDAQ:CTSO)'s Buy rating

Just Now Stockmarketdaily.co Show details

Cytosorbents (NASDAQ:CTSO)‘s stock had its Buy rating Reiterated by analysts at SVB Leerink LLC in a research report issued to clients and investors. A price-to-earnings ratio of #N/A, market cap of 309.2M and a beta of 0.42. Cytosorbents has a twelve month low $6.54 of and a twelve month high of $11.68.

Category: Contact NumberShow more

CytoSorb® Registered and Commercially Available in Singapore

8 hours ago Finance.yahoo.com Show details

CytoSorbents Corporation (NASDAQ: CTSO), a critical care leader commercializing its CytoSorb® blood purification technology to treat deadly conditions in the intensive care unit (ICU) and cardiac

Category: Contact NumberShow more

Cytosorbents Corporation (CTSO): This qtrly results number

2 hours ago Investorshub.advfn.com Show details

Current Report Filing (8-k) Edgar (US Regulatory) - 9/14/2021 5:01:28 PM CytoSorbents to Host International Webinar on the Worldwide Experience Using CytoSorb® in Critically Ill Patients with COVID-19 PR Newswire (US) - 9/14/2021 9:25:00 AM: CytoSorbents Commemorates World Sepsis Day and Sepsis Awareness Month with Key Sepsis-Related …

Category: Contact NumberShow more

CytoSorbents Provides Preliminary Third Quarter Business

2 hours ago Wfmz.com Show details

MONMOUTH JUNCTION, N.J., Oct. 12, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using

Category: Contact NumberShow more

CYTOSORBENTS CORPORATION : Shareholders Board Members

5 hours ago Marketscreener.com Show details

CytoSorbents Corporation is a critical care focused immunotherapy company. The Company is focused on investigating and commercializing blood purification technology to reduce uncontrolled inflammation in patients with focus in preventing or treating multiple organ failure.

Category: Contact NumberShow more

CytoSorbents Corporation (CTSO) Dividend History, Dates

7 hours ago Stockanalysis.com Show details

1 week ago - CytoSorbents Announces Availability of Preliminary Data Abstracts from Two Endocarditis Studies, including the REMOVE study, to be Presented at the EACTS Conference - PRNewsWire1 month ago - CytoSorbents to Host International Webinar on the Worldwide Experience Using CytoSorb® in Critically Ill Patients with COVID-19 - PRNewsWire

Category: Contact NumberShow more

CytoSorbents Provides Preliminary Third Quarter Business

1 hours ago Prnewswire.com Show details

CytoSorbents Provides Preliminary Third Quarter Business Update and Revised 2021 Product Revenue Guidance. Tweet this Total revenue, including product sales and grant income, for Q3 2021 was $9.7

Category: Contact NumberShow more

Jobs with CytoSorbents, Inc. BioSpace

9 hours ago Biospace.com Show details

About CytoSorbents, Inc. CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb is CE Mark certified and is currently distributed in 37 countries around the world as a safe and effective extracorporeal cytokine adsorber, designed to reduce the “cytokine storm” or “cytokine release syndrome” …

Category: Contact NumberShow more

CYTOSORBENTS CORP : Other Events (form 8K) MarketScreener

1 hours ago Marketscreener.com Show details

Item 8.01 Other Events On October 14, 2021, CytoSorbents Corporation (the "Company") issued a press release announcing that the first patient has been enrolled in the Safe and Timely Antithrombotic Removal-Ticagrelor (STAR-T) double-blind, randomized, controlled clinical trial designed to support FDA marketing approval of the DrugSorb-ATR™ …

Category: Contact NumberShow more

Mycotoxin Adsorption with Hemocompatible Porous Polymer

6 hours ago Sbir.gov Show details

Acute exposure to mycotoxins can lead to systemic toxicity and even death. With no specific treatment available, aflatoxin and trichothecene T-2toxin, in particular, are of concern as potential biological weapons due to their toxicity, thermal and UV stability and easy accessibility.

Category: Contact NumberShow more

CytoSorbents to Host International Webinar on the

5 hours ago Finance.yahoo.com Show details

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery announces an upcoming live webinar to provide a global

Category: Contact NumberShow more

BTL Nederland STRATEGIC SOLUTIONS FOR CHEMISTRY

9 hours ago Nl.linkedin.com Show details

BTL Nederland is a consultancy and project management company in the fields of chemical and material science. We provide versatile solutions for technology analysis, product design and development and guidance in manufacturing scale-up and production. By applying our valued knowledge and extensive experience, we have assisted clients from

Title: STRATEGIC SOLUTIONS …
Location: Amsterdam, Noord-Holland, Nederland

Category: Contact NumberShow more

Cytosorbents : Q4 2020 Presentation MarketScreener

5 hours ago Marketscreener.com Show details

Working To Save Lives. Q4 2020 and Full Year 2020 Earnings Conference Call. March 9, 2021. Conference Call Participants. Moderator: Amy Vogel CytoSorbents Corporation. Phillip Chan, MD, PhD-Chief Executive Officer Vincent Capponi, MS-Chief Operating Officer and President. Kathleen Bloch, MBA, CPA-Chief Financial Officer. Efthymios "Makis" Deliargyris, …

Category: Contact NumberShow more

CytoSorbents Corporation hiring SAS Programmer in

8 hours ago Linkedin.com Show details

CytoSorbents, a critical care leader specializing in blood purification technology to treat deadly conditions in critically ill and cardiac surgery patients, is seeking a SAS Programmer to support

Category: Contact NumberShow more

Current Report Filing (8k)

4 hours ago Ih.advfn.com Show details

CTSO CytoSorbents Corporation Current Report Filing (8-k) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Category: Contact NumberShow more

CytoSorbents Corporation hiring Process Engineer in

Just Now Linkedin.com Show details

CytoSorbents, a medical device company specializing in blood purification using porous polymer technology, is recruiting for an enthusiastic Process Engineer to support daily and long-term

Category: Contact NumberShow more

CytoSorbents Corporation hiring Senior Polymer Chemist in

6 hours ago Linkedin.com Show details

Posted 3:16:04 PM. CytoSorbents, a critical care immunotherapy leader, specializes in blood purification technology…See this and similar jobs on LinkedIn.

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

Are there any clinical studies for cytosorb therapy?

CytoSorbents conducts its own studies but since the CytoSorb therapy has been CE-marked, clinicians have also been investigating the effects of the therapy in investigator-initiated studies. Studies initiated by CytoSorbents:

What does cytosorbents do in the icu?

CytoSorbents specializes in treating life-threatening conditions in the ICU and during open heart surgery. The company is committed to serving the best interests of our patients and their families, our customers, our employees, and our shareholders. Video Player is loading. This is a modal window.

Why is cytosorb therapy important for covid 19 patients?

COVID-19 & CytoSorb Therapy* CytoSorb Therapy may be a promising and important therapeutic option to help manage the serious complications caused by cytokine storm and hyperinflammation in critically ill COVID-19 infected patients.

Brand New Updated

Popular Brands

Costco
Cisco
Ccu
Cae